The EMBO Journal
 
Advanced search
Journal home
Aims and scope
Current issue
Advance Online Publication
Web Focuses
Archive:-
Browse by issue
Browse by subject
Browse by category
Free online sample issue
Press releases
Authors & Referees
Editorial process
Guide for authors
Submit an article
Guide for referees
Editorial Team, Senior Advisors and Advisory Editorial Board
Contact Editorial office
Customer services
Subscribe
Order sample copy
Purchase articles
Reprints and permissions
Contact NPG
Advertising
EMBO
www.embo.org
New EMBO Member's Review
Subject Categories: Signal Transduction | Cellular Metabolism
The EMBO Journal (2006) 25, 1419–1425, doi:10.1038/sj.emboj.7601049
Published online 16 March 2006
Endocrine functions of bile acids
Sander M Houten1, 5, Mitsuhiro Watanabe2, 5 and Johan Auwerx2, 3, 4
1 Laboratory Genetic Metabolic Diseases, Academic Medical Center, Amsterdam, The Netherlands
2 Institut de Génétique et Biologie Moléculaire et Cellulaire (IGBMC), CNRS/INSERM/ULP, Illkirch, France
3 Institut Clinique de la Souris, Illkirch, France
4 Laboratoire de Biochimie Générale et Spécialisée, Hôpitaux Universitaires de Strasbourg, Strasbourg, France

To whom correspondence should be addressed
Johan Auwerx, Institut de Génétique et Biologie Moléculaire et Cellulaire, 1 rue Laurent Fries, Parc d'Innovation, BP10142, 67404 Illkirch, France. Tel.: +33 388 653425; Fax: +33 388 653201; E-mail: auwerx@igbmc.u-strasbg.fr

5 These authors contributed equally to this work

Received 9 November 2005; Accepted 24 February 2006; Published online 16 March 2006.
Abstract
Bile acids (BAs), a group of structurally diverse molecules that are primarily synthesized in the liver from cholesterol, are the chief components of bile. Besides their well-established roles in dietary lipid absorption and cholesterol homeostasis, it has recently emerged that BAs are also signaling molecules, with systemic endocrine functions. BAs activate mitogen-activated protein kinase pathways, are ligands for the G-protein-coupled receptor TGR5, and activate nuclear hormone receptors such as farnesoid X receptor alpha. Through activation of these diverse signaling pathways, BAs can regulate their own enterohepatic circulation, but also triglyceride, cholesterol, energy, and glucose homeostasis. Thus, BA-controlled signaling pathways are promising novel drug targets to treat common metabolic diseases, such as obesity, type II diabetes, hyperlipidemia, and atherosclerosis.
Keywords: bile acids, gene expression, metabolism, nuclear receptors, signaling
Top

MORE ARTICLES LIKE THIS

These links to content published by NPG are automatically generated

NEWS AND VIEWS

A sharper image of SHP

Nature Medicine News and Views (01 Aug 2002)

Chipping away at gallstones

Nature Medicine News and Views (01 Dec 2004)

Research News

Nature Medicine News and Views (01 Jul 2002)

?Orphans? meet cholesterol

Nature Medicine News and Views (01 Oct 2000)

Send to a friendEmail link to a friend
PDFDownload PDF
Full textFull text
Next article
Table of contents
rights and permissionsRights and permissions
order commercial reprintsReprints
ToC alertRegister for table of contents by email
  Privacy policy Copyright © 2006 by the European Molecular Biology Organization